Last reviewed · How we verify
NCT05757180: RASPERA
Recalling and Anticipating Specific Positive Events to Boost Resilience in Adolescents
NA trial testing Positive Events Training (PET) in Specific Positive Memories in 191 participants. Completed in 13 May 2023.
13 May 2023
Quick facts
| Lead sponsor | Prof. dr. Filip Raes |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 191 |
| Start date | 21 October 2022 |
| Primary completion | 13 May 2023 |
| Estimated completion | 13 May 2023 |
| Sites | 5 locations across Belgium |
Drugs / interventions tested
- Positive Events Training (PET)
- CREAtive writing Training (CREAT)
Conditions studied
- Specific Positive Memories — all drugs for Specific Positive Memories →
- Specific Positive Future Events — all drugs for Specific Positive Future Events →
- Resilience — all drugs for Resilience →
- Mental Wellbeing — all drugs for Mental Wellbeing →
Sponsor
Prof. dr. Filip Raes
Who can join
Adults 12 to 16, any sex, with Specific Positive Memories or Specific Positive Future Events. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Many young people are experiencing stress-related mental health problems, with some recent studies suggesting this number is increasing. Especially now, in the context of the COVID-19 pandemic, there is a significant increase in depression and anxiety in adolescents. An important way to help address this challenge is not so much to focus on trying to repair what makes young people vulnerable but to focus on building resilience. Resilience refers to the ability to successfully deal with stressful experiences. Recent research shows that being able to vividly remember and imagine positive events can buffer the negative consequences of stress, and makes a convincing case that training adolescents in recalling and anticipating positive events would promote resilience and thereby improve their mental wellbeing. And this is exactly what the current project sets out to do for the very first time. Adolescents will receive a playful group-training in school to make them better at recalling and anticipating positive events, which is expected to help them to bounce back more swiftly from challenging or otherwise stressful life events. The investigators predict that youngsters who follow our Positive Event Training will experience more positive emotions, will show improved resilience and report better mental wellbeing. The investigators will also develop a free online training protocol for teachers so that schools can provide this resilience program on their own, without the need of external professional trainers.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Study protocol for a randomized controlled trial of the RASPERA project: recalling and anticipating specific positive events to boost resilience in adolescents.
Loyen E, Bogaert L, Hallford DJ, D'Argembeau A, et al · · 2023 · PMID 38074707 · DOI 10.3389/fpubh.2023.1216988
Verify or expand the search:
- PubMed search for NCT05757180
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Prof. dr. Filip Raes trials
Trials by the same sponsor.
- NCT04159272 — Effects of Mindfulness Training on the Emotional Experience and (Non-) Acceptance of Emotions in Adolescents · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05757180 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Prof. dr. Filip Raes
- Last refreshed: 7 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05757180.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing